| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 GBDDI Collaborators The Lancet 396 (10258), 1204-1222, 2020 | 7446 | 2020 |
| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to … C Fitzmaurice, C Allen, RM Barber, L Barregard, ZA Bhutta, H Brenner, ... JAMA oncology 3 (4), 524-548, 2017 | 6992 | 2017 |
| Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of … GBDCD Collaborators | 6633* | 2018 |
| Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study KE Rudd, SC Johnson, KM Agesa, KA Shackelford, D Tsoi, DR Kievlan, ... The Lancet 395 (10219), 200-211, 2020 | 4298 | 2020 |
| Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 GBDM Collaborators The Lancet, 2018 | 954 | 2018 |
| Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic … GBDSDG Collaborators The Lancet, 2018 | 492 | 2018 |
| The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016 ISLDBICVD Collaborators | 336* | 2018 |
| Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study GBDT Collaborators The Lancet Infectious Diseases, 2018 | 182 | 2018 |
| A systematic review of allostatic load in relation to socioeconomic position: Poor fidelity and major inconsistencies in biomarkers employed SC Johnson, FL Cavallaro, L David A Social Science and Medicine, 2017 | 124 | 2017 |
| Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study JS Lou, DM Dimitrova, BS Park, SC Johnson, R Eaton, G Arnold, JG Nutt Clinical neuropharmacology 32 (6), 305-310, 2009 | 91 | 2009 |
| Public health utility of cause of death data: applying empirical algorithms to improve data quality SC Johnson, M Cunningham, IN Dippenaar, F Sharara, EE Wool, ... BMC medical informatics and decision making 21 (1), 175, 2021 | 70 | 2021 |
| All-cause and cause-specific mortality among people with severe mental illness in Brazil's public health system, 2000–15: a retrospective study APS Melo, IN Dippenaar, SC Johnson, ND Weaver, F de Assis Acurcio, ... The Lancet Psychiatry 9 (10), 771-781, 2022 | 20 | 2022 |
| Effect of expectancy and personality on cortical excitability in Parkinson's disease JS Lou, DM Dimitrova, R Hammerschlag, J Nutt, EA Hunt, RW Eaton, ... Movement Disorders 28 (9), 1257-1262, 2013 | 18 | 2013 |
| Modafinil reduces fatigue in PD-A double-blind, placebo-controlled pilot study JS Lou, D Dimitrova, S Johnson, R Eaton, J Nutt Annals of Neurology 62, S8-S8, 2007 | 4 | 2007 |
| Apocrine metaplasia: a new type of müllerian metaplasia. C Allen, S Johnson Journal of clinical pathology 46 (6), 569, 1993 | 3 | 1993 |
| Openness to migrate internationally for a job: evidence from LinkedIn data in Europe D Perrotta, SC Johnson, T Theile, A Grow, H de Valk, E Zagheni Proceedings of the International AAAI Conference on Web and Social Media 16 …, 2022 | 2 | 2022 |
| Expectancy, self-efficacy, and placebo effect in PD JS Lou, D Dimitrova, S Johnson, M Davis, G Arnold, W Gregory, J Nutt ANNALS OF NEUROLOGY 64, S55-S55, 2008 | | 2008 |
